Diversified Enterprises’s AstraZeneca AZN Stock Holding History

Diversified Enterprises’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$850K	Buy	5,263 +609	+13%	+$101K	0.04%	198
2026 Q2	$882K	Sell	4,654 -227	-5%	-$42.7K	0.04%	177
2026 Q1	$963K	Buy	4,881 +371	+8%	+$71.5K	0.05%	162
2025 Q4	$829K	Buy	4,510 +1,008	+29%	+$177K	0.05%	154
2025 Q3	$537K	Buy	3,502 +20	+0.6%	+$3.03K	0.04%	157
2025 Q2	$487K	Sell	3,482 -273	-7%	-$38.3K	0.04%	164
2025 Q1	$552K	Buy	3,755 +1,654	+79%	+$239K	0.05%	152
2024 Q4	$275K	Sell	2,101 -24	-1%	-$3.36K	0.03%	200
2024 Q3	$331K	Buy	+2,125	New	+$343K	0.04%	164

Other funds holding AZN

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Generali Asset Management Trieste, Italy $5.73B AUM 29.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Diversified Enterprises's AZN Position: Q3 2026 in Review

Diversified Enterprises increased its AstraZeneca (AZN) stake by 13% in Q3 2026, buying an estimated $101K and bringing the position to 5,263 shares worth $850K. The position accounts for 0.04% of the portfolio, ranked #198.

Diversified Enterprises first reported a position in AZN in Q3 2024 and has held it in 9 quarters since. The position peaked at $963K in Q1 2026. 551 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Diversified Enterprises held 5,263 shares of AstraZeneca worth $850K as of Q3 2026.
Diversified Enterprises bought 609 AstraZeneca shares in Q3 2026, an estimated $101K.
AstraZeneca made up 0.04% of Diversified Enterprises's portfolio in Q3 2026, its #198 holding.
Diversified Enterprises first reported a position in AstraZeneca in Q3 2024 and has held it in 9 quarters since.
Diversified Enterprises's AstraZeneca position peaked at $963K in Q1 2026.
551 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.